1. Home
  2. EML vs GNLX Comparison

EML vs GNLX Comparison

Compare EML & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

N/A

Current Price

$25.55

Market Cap

152.9M

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.75

Market Cap

123.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EML
GNLX
Founded
1858
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
123.1M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
EML
GNLX
Price
$25.55
$2.75
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
9.0K
319.0K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
9.47
EPS
1.04
N/A
Revenue
$248,970,345.00
$8,000.00
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$2.29
52 Week High
$29.91
$8.54

Technical Indicators

Market Signals
Indicator
EML
GNLX
Relative Strength Index (RSI) N/A 49.99
Support Level N/A $2.71
Resistance Level N/A $2.98
Average True Range (ATR) 0.00 0.18
MACD 0.00 0.01
Stochastic Oscillator 0.00 84.38

Price Performance

Historical Comparison
EML
GNLX

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: